RecruitingPhase 1Phase 2NCT05774704

Curcumin and Retinal Study

Curcumin and Retinal Amyloid-beta Pilot Study


Sponsor

Texas Tech University Health Sciences Center

Enrollment

60 participants

Start Date

Aug 21, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.


Eligibility

Min Age: 40 YearsMax Age: 89 Years

Inclusion Criteria3

  • Both male and female, age 40 - 89 years.
  • Diagnosed with Aβ deposits in retina (peripheral superior quadrants)--to be confirmed after consent obtained. If there is documentation the potential participant has been diagnosed with Aβ deposits in retina within 6 months before the consent session, we will use this diagnosis/documentation for eligibility criteria. Otherwise, the ophthalmic exam will be repeated after consent is obtained for the study.
  • No pre-existing liver or kidney diseases by self-report.

Exclusion Criteria5

  • Patients with ocular diseases (macular degeneration, severe diabetes retinopathy)
  • Had used systemic antibiotics within 1 month prior to the start of the study intervention
  • Had taken any turmeric or curcumin products within 2 weeks prior to the start of the study intervention
  • Had a known allergy to black pepper
  • Women that are pregnant or breastfeeding

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLow curcumin group

One curcumin capsule (250 mg curcumin) after each meal, 3 times a day for 2 weeks.

DRUGHigh curcumin group

One curcumin capsule (500 mg curcumin) after each meal, 3 times a day for 2 weeks.


Locations(1)

Texas Tech University Health Sciences Center

Lubbock, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05774704


Related Trials